The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Induction of Tumors in Mice by Genomic Hypomethylation
Abstract
Genome-wide DNA hypomethylation occurs in many human cancers, but whether this epigenetic change is a cause or consequence of tumorigenesis has been unclear. To explore this phenomenon, we generated mice carrying a hypomorphic DNA methyltransferase 1 ( Dnmt1 ) allele, which reduces Dnmt1 expression to 10% of wild-type levels and results in substantial genome-wide hypomethylation in all tissues. The mutant mice were runted at birth, and at 4 to 8 months of age they developed aggressive T cell lymphomas that displayed a high frequency of chromosome 15 trisomy. These results indicate that DNA hypomethylation plays a causal role in tumor formation, possibly by promoting chromosomal instability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Reduced DNA methylation (hypomethylation) in mice increases the risk of aneuploidy and cancer (Gaudet et al., 2003)”
From The Aging Epigenome (2016) · cites this paper as Gaudet et al., 2003
In the citing paper
“Indeed, the global DNA hypomethylation, especially occurring on intragenic regions, is a general feature of most tumours [35][36][37] .”
From Intragenic DNA methylation prevents spurious transcription initiation (2017) · cites this paper as [36]
Citations
Cites
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
Self-citationThe fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
Li, E., Bestor, T. H., & Jaenisch, R. (1992) · Cell · doi:10.1016/0092-8674(92)90611-f · Cited by 3,984
Self-citationHypomethylation distinguishes genes of some human cancers from their normal counterparts
Feinberg, A. P., & Vogelstein, B. (1983) · Nature · doi:10.1038/301089a0 · Cited by 2,437
Loss of the Suv39h Histone Methyltransferases Impairs Mammalian Heterochromatin and Genome Stability
Peters, A. H. F. M., O'Carroll, D., Scherthan, H., Mechtler, K., Sauer, S., Schöfer, C., Weipoltshammer, K., Pagani, M., Lachner, M., Kohlmaier, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00542-6 · Cited by 1,766
DNA methylation in cancer: too much, but also too little
Ehrlich, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205651 · Cited by 1,538
Chromosomal Instability and Tumors Promoted by DNA Hypomethylation
Eden, A., Gaudet, F., Waghmare, A., & Jaenisch, R. (2003) · Science · doi:10.1126/science.1083557 · Cited by 1,399
Self-citationXu, G.-L., Bestor, T. H., Bourc'his, D., Hsieh, C.-L., Tommerup, N., Bugge, M., Hulten, M., Qu, X., Russo, J. J., & Viegas-Péquignot, E. (1999) · Nature · doi:10.1038/46052 · Cited by 1,203
Transcription of IAP endogenous retroviruses is constrained by cytosine methylation
Walsh, C. P., Chaillet, J. R., & Bestor, T. H. (1998) · Nature Genetics · doi:10.1038/2413 · Cited by 1,105
DNA hypomethylation leads to elevated mutation rates
Chen, R. Z., Pettersson, U., Beard, C., Jackson-Grusby, L., & Jaenisch, R. (1998) · Nature · doi:10.1038/25779 · Cited by 954
Self-citation
Research works printed but not linked: 3
- S. Cory, D. L. Vaux, A. Strasser, A. W. Harris, J. M. Adams, Cancer Res.59 (suppl.), 1685s (1999).
- E. Wainfan, L. A. Poirier, Cancer Res.52, 2071s (1992).
- V. Zagonelet al., Leukemia7 (suppl. 1), 30 (1993).
Cited by
Items 401–500 of 1,001
Epigenomic heterogeneity as a source of tumour evolution
Laisné, M., Lupien, M., & Vallot, C. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00757-9 · Cited by 111
Liao, Y., Liu, S., Lee, C.-H., Yen, C., Chuang, P., Chen, C., Tsai, T., Huang, S., Lee, Y. W., & Chen, Y. A. (2008) · International Journal of Cancer · doi:10.1002/ijc.23979 · Cited by 83
“It has been reported that mice with reduced level of Dnmt1 suffer from DNA hypomethylation and result in tumor formation.(35) In addition, DNMT3b cooperates with DNMT1 to maintain DNA methylation and gene silencing in human cancer cells.”
BackgroundThe absence of p53 is critical for the induction of apoptosis by 5-aza-2′-deoxycytidine
Nieto, M. D., Samper, E., Fraga, M. F., de Buitrago, G. G., Esteller, M., & Serrano, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207175 · Cited by 92
“It has been reported that hypomethylation due to genetic manipulation of DNMT1 results in genetic instability (Chen et al., 1998; Eden et al., 2003; Gaudet et al., 2003) and p53-dependent apoptosis (Jackson-Grusby et al., 2001; Stancheva et al., 2001).”
BackgroundAlakhova, D. Y., Zhao, Y., Li, S., & Kabanov, A. V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072238 · Cited by 91
“For example it was shown that reducing the methylation by 10% from normal levels was sufficient to induce cancer development in mice [55].”
BackgroundMethods In Dna Methylation Profiling
Zuo, T., Tycko, B., Liu, T.-M., Lin, H.-J. L., & Huang, T. H. ‐. (2009) · Epigenomics · doi:10.2217/epi.09.31 · Cited by 99
DNA Methylation, Nuclear Organization, and Cancer
Madakashira, B. P., & Sadler, K. C. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00076 · Cited by 87
“In mice, a strong hypomorphic allele of the DNA methyltransferase, Dnmt1, causes DNA hypomethylation and genomic instability leading to aggressive T-cell lymphoma (Gaudet et al., 2003) and heterozygosity for this allele synergized with Nf1 and Tp53 to accelerate sarcoma formation (Eden et al.”
BackgroundCalvisi, D. F., Simile, M. M., Ladu, S., Pellegrino, R., Murtas, V. D., Pinna, F., Tomasi, M. L., Frau, M., Virdis, P., Miglio, M. R. D., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22940 · Cited by 82
TET methylcytosine oxidases: new insights from a decade of research
Lio, C. J., Yue, X., López-Moyado, I. F., Tahiliani, M., Aravind, L., & Rao, A. (2020) · Journal of Biosciences · doi:10.1007/s12038-019-9973-4 · Cited by 85
“DNA hypomethylation has been associated with increased mutational load and genome instability (Chen et al. 1998; Eden et al. 2003; Gaudet et al. 2003).”
BackgroundInsufficient DNA methylation affects healthy aging and promotes age-related health problems
Liu, L., van Groen, T., Kadish, I., Li, Y., Wang, D., James, S. R., Karpf, A. R., & Tollefsbol, T. O. (2011) · Clinical Epigenetics · doi:10.1007/s13148-011-0042-6 · Cited by 91
“The elevated incidence of tumor formation in old Dnmt1+/− mice is consistent with previous observations that mice carrying a hypomorphic Dnmt1 allele display severe genomic hypomethylation and are prone to the development of aggressive T cell lymphomas at early ages (Gaudet et al. 2003).”
BackgroundMiRNAs, epigenetics, and cancer
ROUHI, A. M., Mager, D. L., Humphries, R. K., & Kuchenbauer, F. C. (2008) · Mammalian Genome · doi:10.1007/s00335-008-9133-x · Cited by 90
“Hypomethylation leads to genomic instability (Eden et al. 2003; Gaudet et al. 2003), the acti-”
BackgroundPotential of DNMT and its Epigenetic Regulation for Lung Cancer Therapy
Tang, M., Xu, W., Qizhao, W., Xiao, W., & Xu, R. (2009) · Current Genomics · doi:10.2174/138920209788920994 · Cited by 86
“phic and a null allele of Dnmt1 developed aggressive T cell lymphomas [179].”
BackgroundDemethylating Agents in the Treatment of Cancer
Howell, P., Liu, Z., & Khong, H. T. (2010) · Pharmaceuticals · doi:10.3390/ph3072022 · Cited by 84
Common features of chromatin in aging and cancer: cause or coincidence?
Zane, L. K., Sharma, V., & Misteli, T. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.07.001 · Cited by 89
Chaib, H., Nebbioso, A., Prébet, T., Castellano, R., Garbit, S., Restouin, A., Vey, N., Altucci, L., & Collette, Y. (2011) · Leukemia · doi:10.1038/leu.2011.271 · Cited by 80
Deregulation of Retroelements as an Emerging Therapeutic Opportunity in Cancer
Ishak, C. A., Classon, M., & Carvalho, D. D. D. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.05.008 · Cited by 83
DNA Methylation, Genomic Silencing, and Links to Nutrition and Cancer
McCabe, D. C., & Caudill, M. A. (2005) · Nutrition Reviews · doi:10.1111/j.1753-4887.2005.tb00136.x · Cited by 78
The role of epigenetic inactivation of 14-3-3σ in human cancer
Lodygin, D., & Hermeking, H. (2005) · Cell Research · doi:10.1038/sj.cr.7290292 · Cited by 78
“Global hypomethylation was shown to cause genomic instability which in turn may promote secondary genetic alterations [ 7 , 8], whereas local hypermethylation of promoter regions is associated with transcriptional silencing”
BackgroundKoslowski, M., Luxemburger, U., Türeci, Ö., & Şahin, U. (2010) · Oncogene · doi:10.1038/onc.2010.481 · Cited by 90
Gonzalgo, M. L., & Liang, G. (2007) · Nature Protocols · doi:10.1038/nprot.2007.271 · Cited by 82
“271" language="eng" publish="issue" relation="no"> Introduction Alterations in the patterns of DNA methylation are among the earliest and most common events in tumorigenesi”
BackgroundWhole genome DNA methylation signature of HER2-positive breast cancer
Lindqvist, B. M., Wingren, S., Motlagh, P. B., & Nilsson, T. (2014) · Epigenetics · doi:10.4161/epi.29632 · Cited by 81
Repetitive DNA hypomethylation in the advanced phase of chronic myeloid leukemia
Román‐Gómez, J., Jiménez‐Velasco, A., Agirre, X., Castillejo, J. A., Navarro, G., José‐Eneriz, E. S., Gárate, L., Cordeu, L., Cervantes, F., Prósper, F., et al. (2007) · Leukemia Research · doi:10.1016/j.leukres.2007.07.021 · Cited by 78
Regulation of pluripotency in male germline stem cells by Dmrt1
Takashima, S., Hirose, M., Ogonuki, N., Ebisuya, M., Inoue, K., Kanatsu‐Shinohara, M., Tanaka, T. S. T., Nishida, E., Ogura, A., & Shinohara, T. (2013) · Genes & Development · doi:10.1101/gad.220194.113 · Cited by 84
“Because deficiency of Dnmt1 causes somatic cell tumors (Gaudet et al. 2003), acquisition of pluripotency in GS cells is suggested to share similarities with tumorigenesis.”
BackgroundInfluentialZhu, Z.-Z., Sparrow, D., Hou, L., Tarantini, L., Bollati, V., Litonjua, A. A., Zanobetti, A., Vokonas, P., Wright, R. O., Baccarelli, A., et al. (2010) · Cancer Causes & Control · doi:10.1007/s10552-010-9715-2 · Cited by 80
“In addition, global DNA hypomethylation is expected to lead to the direct reactivation and subsequent expression of LINE-1 transcripts [32, 33], which may participate in carcinogenesis through insertion into functional sequences, homologous recombination, and deregulation of protein expression [14, 31].”
Electrochemical biosensing strategies for DNA methylation analysis
Hossain, T., Mahmudunnabi, R. G., Masud, M. K., Islam, M. N., Ooi, L., Konstantinov, K., Hossain, M. S. A., Martinac, B., Alıcı, G., Nguyen, N., et al. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.02.026 · Cited by 82
“On the other hand, these CpGs are hypomethylated in cancer cells with association to higher genomic instability (Bird, 1992; Baylin and Ohm, 2006; Gaudet et al., 2003).”
BackgroundWu, C. F., Lei, H., & Duan, Y. (2005) · Journal of the American Chemical Society · doi:10.1021/ja050767x · Cited by 77
Epigenetic Regulation of Cancer-Associated Genes in Ovarian Cancer
Kwon, M. J., & Shin, Y. K. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12020983 · Cited by 84
“DNA hypomethylation agents might actually promote the development of some tumors, possibly by inducing chromosomal instability [130,131].”
BackgroundLu, H., Chai, C., Lim, T. C., Leong, M. F., Lim, J. K., Gao, S., Lim, K. L., & Wan, A. C. A. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.050 · Cited by 77
“For example, the use of 5-azacytidine has been shown to cause tumor in mice with global alteration of DNA methylation level [28,47].”
BackgroundLoriot, A. E., Plaen, E. D., Boon, T., & Smet, C. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510469200 · Cited by 77
Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesis
Hlady, R. A., Nováková, S., Opavska, J., Klinkebiel, D. L., Peters, S. L., Bies, J., Hannah, J. D., Iqbal, J., Anderson, K. M., Siebler, H. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57292 · Cited by 93
“For example, genome-wide hypomethylation induced T cell lymphomas in Dnmt1chip/– mice characterized by increased genomic instability (12).”
BackgroundResultInfluentialKawano, H., Saeki, H., Kitao, H., Tsuda, Y., Otsu, H., Ando, K., Ito, S., Egashira, A., Oki, E., Morita, M., et al. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3818-z · Cited by 76
Issa, J. J. (2003) · Current Opinion in Oncology · doi:10.1097/00001622-200311000-00007 · Cited by 80
The Stem Cell Identity of Testicular Cancer
Clark, A. T. (2007) · Stem Cell Reviews and Reports · doi:10.1007/s12015-007-0002-x · Cited by 80
“These germ line-specific epigenetic changes could make the germ line particularly vulnerable to transformation if not programmed correctly [74, 75].”
BackgroundChen, M., Chen, Z.-Q., Cui, P.-G., Yao, X., Li, Y., Li, A.-S., Gong, J.-Q., & Cao, Y.-H. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08505.x · Cited by 75
p66 and p66 of the Mi-2/NuRD complex mediate MBD2 and histone interaction
Marc, B., Gong, Z., Leers, J., & Renkawitz, R. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj437 · Cited by 80
Exploring the Early Steps of Amyloid Peptide Aggregation by Computers
Mousseau, N., & Derreumaux, P. (2005) · Accounts of Chemical Research · doi:10.1021/ar050045a · Cited by 80
Role of MBD2 in gene regulation and tumorigenesis
Berger, J., & Bird, A. (2005) · Biochemical Society Transactions · doi:10.1042/bst0331537 · Cited by 77
Inamura, K., Yamauchi, M., Nishihara, R., Lochhead, P. J., Qian, Z. R., Kuchiba, A., Kim, S. A., Mima, K., Sukawa, Y., Jung, S., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju195 · Cited by 77
Deng, G., Nguyen, A., Tanaka, H., Matsuzaki, K., Bell, I., Mehta, K. R., Terdiman, J. P., Waldman, F. M., Kakar, S., Gum, J. R., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21740 · Cited by 74
Aberrant DNA Methylation in Cutaneous Malignancies
van Doorn, R., Gruis, N. A., Willemze, R., van der Velden, P. A., & Tensen, C. P. (2005) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.07.001 · Cited by 82
New anti-cancer strategies: Epigenetic therapies and biomarkers
Balch, C. (2005) · Frontiers in bioscience · doi:10.2741/1668 · Cited by 77
Ordway, J. M., Williams, K., & Curran, T. (2004) · Oncogene · doi:10.1038/sj.onc.1207483 · Cited by 72
“These changes can also contribute to tumorigenesis, possibly by promoting chromosomal instability (Eden et al., 2003; Gaudet et al., 2003).”
BackgroundSandhu, R., Rivenbark, A. G., Mackler, R. M., Livasy, C., & Coleman, W. B. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2197 · Cited by 77
“pericentromeric regions of certain chromosomes (5-7).”
Yang, A. S., Estecio, M. R., Garcia‐Manero, G., Kantarjian, H. M., & Issa, J. J. (2003) · Science · doi:10.1126/science.1089523 · Cited by 72
Hypoxia selects for androgen independent LNCaP cells with a more malignant geno‐ and phenotype
Butterworth, K. T., McCarthy, H. O., Devlin, A. H., Ming, L., Robson, T., McKEOWN, S. R., & Worthington, J. (2008) · International Journal of Cancer · doi:10.1002/ijc.23418 · Cited by 72
Evolution of cancer stem cells
Bapat, S. A. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.05.001 · Cited by 71
Elhasid, R., Sahar, D., Merling, A., Zivony, Y., Rotem, A., Ben-Arush, M., Izraeli, S., Bercovich, D., & Larisch, S. (2004) · Oncogene · doi:10.1038/sj.onc.1207725 · Cited by 80
“DNA methylation, has long been associated with transcriptional silencing of tumor suppressor genes (Jones, 1999; Malfoy, 2000; Rountree et al., 2001; Jain, 2003; Gaudet et al., 2003).”
BackgroundBaba, Y., Watanabe, M., Murata, A., Shigaki, H., Miyake, K., Ishimoto, T., Iwatsuki, M., Iwagami, S., Yoshida, N., Oki, E., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1645 · Cited by 72
“Global DNA hypomethylation appears to play a crucial role in genomic instability, leading to cancer development (10-12).”
Hervouet, É., Debien, E., Campion, L., Charbord, J., Ménanteau, J., Vallette, F. M., & Cartron, P. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2062 · Cited by 77
On the Complexity of Mechanisms and Consequences of Chromothripsis: An Update
Koltsova, A. S., Pendina, A. A., Efimova, O. A., Chiryaeva, O. G., Kuznetzova, T. V., & Баранов, В. С. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00393 · Cited by 78
DNA methylation and hydroxymethylation in hematologic differentiation and transformation
Ko, M., An, J., & Rao, A. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.10.009 · Cited by 76
Potential of adipose-derived stem cells in muscular regenerative therapies
Forcales, S. V. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00123 · Cited by 74
Müller, H. M., Fiegl, H., Goebel, G., Hubalek, M., Widschwendter, A., Müller‐Holzner, E., Marth, C., & Widschwendter, M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601392 · Cited by 78
“DNA hypomethylation in general seems to play a central role in carcinogenesis, possibly promoted by chromosomal instability (Eden et al, 2003; Gaudet et al, 2003).”
BackgroundDNA Methylation and Cancer Therapy
Szyf, M. (2005) · Springer eBooks · doi:10.1007/b139080 · Cited by 69
The potential role of epigenetic therapy in multiple myeloma
Smith, E. M. K., Boyd, K. D., & Davies, F. E. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07976.x · Cited by 76
“The CpGs in long repetitive sequences are heavily methylated in normal cells and are associated with silencing of junk DNA and genomic stability; in cancer cells these regions have a tendency towards global hypomethylation, which promotes genomic instability (Eden et al, 2003; Gaudet et al, 2003).”
BackgroundDNA Damage, Somatic Aneuploidy, and Malignant Sarcoma Susceptibility in Muscular Dystrophies
Schmidt, W. M., Uddin, M. H., Dysek, S., Moser-Thier, K., Pirker, C., Höger, H., Ambros, I. M., Ambros, P. F., Berger, W., & Bittner, R. E. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002042 · Cited by 77
“Chromosomes 8 and/or 15 are frequently duplicated in T cell tumors [40–41] or transgenic mouse models of acute promyelocytic leukemia [42], and probably contribute to elevated expression of the Junb and/or Myc oncogenes, as suggested for Myc in T cell lymphomas [41].”
BackgroundRoll, J. D., Rivenbark, A. G., Sandhu, R., Parker, J. S., Jones, W. D., Carey, L., Livasy, C., & Coleman, W. B. (2013) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2013.09.001 · Cited by 75
“In addition, genome-wide demethylation can contribute to chromosomal instability by destabilizing pericentromeric regions of certain chromosomes (Eden et al., 2003; Gaudet et al., 2003; Narayan et al., 1998).”
BackgroundKarpinets, T. V., & Foy, B. D. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi079 · Cited by 70
Shen, Y., Takahashi, M., Byun, H., Link, A., Sharma, N., Balaguer, F., Leung, H.-C., Boland, C. R., & Goel, A. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.19604 · Cited by 70
Epigenetic field cancerization in gastrointestinal cancers
Baba, Y., Ishimoto, T., Kurashige, J., Iwatsuki, M., Sakamoto, Y., Yoshida, N., Watanabe, M., & Baba, H. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.03.009 · Cited by 70
Gopinathan, G., & Khosla, S. (2012) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-4525-4_26 · Cited by 71
RGS6 Interacts with DMAP1 and DNMT1 and Inhibits DMAP1 Transcriptional Repressor Activity
Liu, Z., & Fisher, R. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309547200 · Cited by 70
Yamamoto, E., Toyota, M., Suzuki, H., Kondo, Y., Sanomura, T., Murayama, Y., Ohe-Toyota, M., Maruyama, R., Nojima, M., Ashida, M., et al. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0112 · Cited by 69
“Its functional consequences in tumorigenesis remain unclear, although it has been proposed that genomewide hypomethylation gives increase to chromosomal instability (23, 24).”
BackgroundBacterial folate biosynthesis and colorectal cancer risk: more than just a gut feeling
Kok, D. E. G., Steegenga, W. T., Smid, E. J., Zoetendal, E. G., Ulrich, C. M., & Kampman, E. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1522499 · Cited by 71
“DNA hypomethylation is associated with genomic instability and as such can contribute to cancer development or progression (Eden et al. 2003; Gaudet et al. 2003).”
BackgroundBiological Functions of DNA Methyltransferase 1 Require Its Methyltransferase Activity
Damelin, M. I., & Bestor, T. H. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00036-07 · Cited by 84
Long Interspersed Element-1 Methylation Level as a Prognostic Biomarker in Gastrointestinal Cancers
Baba, Y., Yagi, T., Sawayama, H., Hiyoshi, Y., Ishimoto, T., Iwatsuki, M., Miyamoto, Y., Yoshida, N., & Baba, H. (2018) · Digestion · doi:10.1159/000484104 · Cited by 75
Paoli‐Iseppi, R. D., Deagle, B. E., Polanowski, A. M., McMahon, C. R., Dickinson, J. L., Hindell, M. A., & Jarman, S. (2018) · Molecular Ecology Resources · doi:10.1111/1755-0998.12981 · Cited by 81
“In contrast to mammalian and the only other bird study, we found no clear trend of DNA hypomethyla- tion in older animals compared to that in younger individuals (Gaudet et al., 2003; Gryzinska et al., 2016; Portela & Esteller, 2010).”
ResultThe ‘de novo’ DNA methyltransferase Dnmt3b compensates the Dnmt1-deficient intestinal epithelium
Elliott, E. N., Sheaffer, K. L., & Kaestner, K. H. (2016) · eLife · doi:10.7554/elife.12975 · Cited by 72
“Dnmt1 hypomorphic mice exhibit increased chromosomal duplications and rearrangements, and develop invasive T-cell lymphomas at approximately four months of age (Gaudet et al., 2003).”
Porcellini, E., Laprovitera, N., Riefolo, M., Ravaioli, M., Garajova, I., & Ferracin, M. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.049 · Cited by 66
Global DNA Hypomethylation in Peripheral Blood Mononuclear Cells as a Biomarker of Cancer Risk
Friso, S., Udali, S., Guarini, P., Pellegrini, C., Pattini, P., Moruzzi, S., Girelli, D., Pizzolo, F., Martinelli, N., Corrocher, R., et al. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0859 · Cited by 67
“and many studies in rodent models showed that global DNA hypomethylation can, by itself, induce cancer (6).”
BackgroundCruickshanks, H. A., Vafadar-Isfahani, N., Dunican, D. S., Lee, A., Sproul, D., Lund, J. N., Meehan, R. R., & Tufarelli, C. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt438 · Cited by 82
Kamiya, T., Goto, A., Kurokawa, E., Hara, H., & Adachi, T. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1284372 · Cited by 69
The epigenome of testicular germ cell tumors
Lind, G. E., Skotheim, R. I., & Lothe, R. A. (2007) · Apmis · doi:10.1111/j.1600-0463.2007.apm_660.xml.x · Cited by 69
“Studies in mouse models have indicated a causal connection between the reduced levels of 5-methylcytosine and tumor formation (22).”
BackgroundDNA methylation dynamics in muscle development and disease
Carrió, E., & Suelves, M. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00019 · Cited by 83
“, 1987), silencing of genomic elements such as transposons to ensure genomic stability (Walsh et al., 1998; Gaudet et al., 2003), and maintenance of constitutively repressed centromeric and pericentromeric DNA satellite repeats (Gopalakrishnan et al.”
BackgroundCauses and Consequences of Age-Related Changes in DNA Methylation: A Role for ROS?
Rang, F. J., & Boonstra, J. (2014) · Biology · doi:10.3390/biology3020403 · Cited by 69
“Similarly, induced hypomethylation can result in the activation of proto-oncogenes [96,134], but also contributes to genomic instability and increased mutation rates [135,136].”
BackgroundContribution of epigenetic mechanisms to variation in cancer risk among tissues
Klutstein, M., Moss, J., Kaplan, T., & Cedar, H. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616556114 · Cited by 75
“In some cases, it appears that aberrant demethylation may also play a role in tumorigenesis (26, 27).”
BackgroundThe Application of Functional Genomics to Alzheimer’s Disease
Cacabelos, R. (2003) · Pharmacogenomics · doi:10.1517/phgs.4.5.597.23795 · Cited by 72
Shah, M. Y., Vasanthakumar, A., Barnes, N. Y., Figueroa, M. E., Kamp, A., Hendrick, C., Ostler, K. R., Davis, E. M., Lin, S., Anastasi, J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0847 · Cited by 63
“Lymphocytes are very sensitive to changes in DNA methylation because mice expressing a hypomorphic Dnmt1 allele develop aggressive T-cell lymphomas (23, 24).”
Blood-based DNA methylation signatures in cancer: A systematic review
Li, Y., Fan, Z., Meng, Y., Liu, S., & Zhan, H. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166583 · Cited by 78
Compendium of aberrant DNA methylation and histone modifications in cancer
Hattori, N., & Ushijima, T. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.140 · Cited by 77
Genome–epigenome interactions in cancer
Brena, R. M., & Costello, J. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm073 · Cited by 76
DNA methylation and cancer therapy
Szyf, M. (2003) · Drug Resistance Updates · doi:10.1016/j.drup.2003.10.002 · Cited by 65
LINE-1 Methylation Level and Patient Prognosis in a Database of 208 Hepatocellular Carcinomas
Harada, K., Baba, Y., Ishimoto, T., Chikamoto, A., Kosumi, K., Hayashi, H., Nitta, H., Hashimoto, D., Beppu, T., & Baba, H. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-4134-3 · Cited by 71
“Promoter hypermethylation can silence tumor suppressor genes, whereas global DNA hypomethylation appears to play an important role in genomic instability, leading to cancer development.(11,12) Because long interspersed nucleotide element-1 (LINE-1) retrotransposons constitute Electronic supplementary material The onli…”
BackgroundAberrant DNA methylation profiles of inherited and sporadic colorectal cancer
AIFEG, Sahnane, N., Magnoli, F., Bernasconi, B., Tibiletti, M. G., Romualdi, C., Pedroni, M., de Leòn, M. P., Magnani, G., Bonetti, L. R., et al. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0165-2 · Cited by 71
“Genome-wide-DNA hypomethylation is the other early epigenetic alteration that has been observed in sporadic CRCs [17–19], and it has been associated with genomic and chromosomal instability (CIN) [20–23], as well as with the deregulation of gene transcription and activation of retrotransposons [24].”
BackgroundResultUnraveling the epigenetic code of cancer for therapy
Smith, L. T., Otterson, G. A., & Plass, C. (2007) · Trends in Genetics · doi:10.1016/j.tig.2007.07.005 · Cited by 64
Alu and Satα hypomethylation in Helicobacter pylori‐infected gastric mucosae
Yoshida, T., Yamashita, S., Takamura‐Enya, T., Niwa, T., Ando, T., Enomoto, S., Maekita, T., Nakazawa, K., Tatematsu, M., Ichinose, M., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25534 · Cited by 66
Epigenetic Treatment of Hematopoietic Malignancies: In Vivo Targets of Demethylating Agents
Claus, R., Almstedt, M., & Lübbert, M. (2005) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.07.024 · Cited by 65
Applying whole-genome studies of epigenetic regulation to study human disease
Lieb, J. D., Beck, S., Bulyk, M. L., Farnham, P., Hattori, N., Henikoff, S., Liu, X. S., Okumura, K., Shiota, K., Ushijima, T., et al. (2006) · Cytogenetic and Genome Research · doi:10.1159/000091922 · Cited by 66
“Hypomethylation can lead to genomic instability and contribute to tumor formation (Gaudet et al., 2003).”
Epigenetic silencing of 14-3-3sigma in cancer
Lodygin, D., & Hermeking, H. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.03.008 · Cited by 69
DNMT1: catalytic and non-catalytic roles in different biological processes
Mohan, K. N. (2022) · Epigenomics · doi:10.2217/epi-2022-0035 · Cited by 72
Niedzwiecki, M. M., Hall, M. N., Liu, X., Oka, J., Harper, K. N., Slavkovich, V. N., Ilievski, V., Levy, D., van Geen, A., Mey, J. L., et al. (2013) · Environmental Health Perspectives · doi:10.1289/ehp.1206421 · Cited by 65
“Global DNA hypo methylation is associated with genomic instability, including loss of hetero zygosity (Matsuzaki et al. 2005), aneuploidy (Dodge et al. 2005), and chromo somal altera tions (Schulz et al. 2002), and is commonly observed in tumors and transformed cells (Gaudet et al. 2003).”
BackgroundButcher, D. T., Mancini‐DiNardo, D., Archer, T., & Rodenhiser, D. I. (2004) · International Journal of Cancer · doi:10.1002/ijc.20324 · Cited by 66
DNA Methyltransferases Inhibitors from Natural Sources
Zwergel, C., Valente, S., & Mai, A. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150825141505 · Cited by 63
Prognostic Relevance of Aberrant DNA Methylation in G1 and G2 Pancreatic Neuroendocrine Tumors
Stefanoli, M., Rosa, S. L., Sahnane, N., Romualdi, C., Pastorino, R., Marando, A., Capella, C., Sessa, F., & Furlan, D. (2014) · Neuroendocrinology · doi:10.1159/000365449 · Cited by 63
Heideman, M. R., Lancini, C., Proost, N., Yanover, E., Jacobs, H., & Dannenberg, J.-H. (2014) · Haematologica · doi:10.3324/haematol.2013.092643 · Cited by 75
CpG islands: their potential as biomarkers for cancer
Shi, H., Wang, M., & Caldwell, C. W. (2007) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.7.5.519 · Cited by 71
Zhao, Y., Xue, F., Sun, J., Guo, S., Zhang, H., Qiu, B., Geng, J., Gu, J. F., Zhou, X., Wang, W., et al. (2014) · Clinical Epigenetics · doi:10.1186/1868-7083-6-30 · Cited by 68
“According to the accepted hypothesis, aberrant DNA methylation in association with carcinoma is characterized by genome-wide hypomethylation and clustered hypermethylation [24,25].”
Duforestel, M., Nadaradjane, A., Bougras-Cartron, G., Briand, J., Olivier, C., Frenel, J., Vallette, F. M., Lelièvre, S. A., & Cartron, P. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00885 · Cited by 71
“Glyphosate Exposure Is Tumorigenic for MCF10A Cells in a Two-Factor Hit Model Global DNA hypomethylation is potentially tumorigenic (Gaudet et al., 2003; Hervouet et al., 2010; Pacaud et al., 2014).”
BackgroundInfluentialClonal selection of stable aneuploidies in progenitor cells drives high-prevalence tumorigenesisPreprint
Trakala, M., Aggarwal, M., Sniffen, C., Zasadil, L. M., Carroll, A., Ma, D., Su, X. A., Wangsa, D., Meyer, A., Sieben, C. J., et al. (2021) · Genes & Development · doi:10.1101/gad.348341.121 · Cited by 61
“These results suggested that MYC, a well-known driverof T-cell lymphoma and other hematopoietic malignancies (Gaudet et al. 2003; Meyer and Penn 2008), was also driving tumorigenesis in the Cdc20 Δ /AAA CIN model.”
BackgroundResultTumour heterogeneity and evolutionary dynamics in colorectal cancer
Chan, D. K. H., & Buczacki, S. J. A. (2021) · Oncogenesis · doi:10.1038/s41389-021-00342-x · Cited by 72
Chromosomal Instability in Oral Cancer Cells
Reshmi, S. C., & Gollin, S. M. (2005) · Journal of Dental Research · doi:10.1177/154405910508400203 · Cited by 62
Metadata
- Authors
- Gaudet, F., Hodgson, J. G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J. W., Leonhardt, H., & Jaenisch, R.
- Affiliations
- Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
- University of California, San Francisco (US)
- Corresponding author
- Jaenisch, Rudolf
- Venue
- Science
- Published
- 2003-04-18
- Volume
- 300
- Issue
- 5618
- Pages
- 489-492
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1990381590
- Cited by
- 1,499
- References
- 34
- Citations by year
- 2026: 12 · 2025: 25 · 2024: 20 · 2023: 36 · 2022: 40 · 2021: 43 · 2020: 52 · 2019: 50 · 2018: 48 · 2017: 48 · 2016: 63 · 2015: 75 · 2014: 57 · 2013: 94 · 2012: 99
- FWCI
- 34.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Funders
- National Cancer Institute (R01CA087869, CA 87869)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- DNA hypomethylation, DNMT1, T-cell lymphoma, tumor induction, epigenetic silencing, chromosomal instability, mouse model
- MeSH terms
- DNA (Cytosine-5-)-Methyltransferase 1, Alleles, Animals, Birth Weight, Cell Transformation, Neoplastic, Chromosome Aberrations, DNA (Cytosine-5-)-Methyltransferases, Heterozygote, Mice, Transgenic, Moloney murine leukemia virus, Trisomy, Virus Activation, Gene Rearrangement, Gene Rearrangement, beta-Chain T-Cell Antigen Receptor, Gene Expression, Gene Expression Regulation, Neoplastic, Genes, myc, Lymphoma, T-Cell, DNA Methylation, Loss of Heterozygosity, Endogenous Retroviruses, Chromosomes, Mammalian, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.